Amgen Inc. DL-Notes 2026(26/31)

Type of financial instrument

Corporate Bond

Sub-Type

Technology

Yield

4.99

Yield spread Bundesanleihe

2.1009

Tradable for private investors

No

Minimum amount tradeable unit

2,000.00

Maturity

19/02/2031

Interest Rate

4.20 %

Currency

US Dollar

Facts & figures

Price data

TRADE PLATFORM
LAST PRICE / YIELD97.069 G / 4.990 Units
PRICE DETERMINATION TIME07/22/2026 / 09:46:50 PM
DAILY VOLUME (NOMINAL)0
YIELD SPREAD2.1009
FIXINGPRICE-
DAILY HIGH / LOW97.2497.069
PREV. DAY'S PRICE97.251 (07/21)
CHANGE DAY BEFORE
-0.18
-0.19 %
52 WEEK HIGH / LOW (-) (-)
More Price Information

Master Data

WKN
A4EQNT
ISIN
US031162DV90
SYMBOL
-
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Corporate Bond
SUB-TYPETechnology
ISSUER
Amgen Inc.
S&P RATINGPlease log in to view this field
(TRADING) SEGMENT / TICKS
-/ -
TRADING HOURS
07:30:00 AM - 10:00:00 PM
INTEREST RATE
4.20 %
INTEREST RUN FROM
19/02/2026
NEXT INTEREST PAYMENT
19/08/2026
UNIT INTEREST FROM NOMINAL AMMOUNT
1.832 %
TRADING CURRENCY / NOTATION
US Dollar/ Percent
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
QUOTATION
Continuous trading
ISSUING VOLUME
0
MINIMUM AMOUNT TRADEABLE UNIT
2,000.00
SMALLEST TRADEABLE UNIT
1,000.00
MATURITY
19/02/2031
MARKET MAKER
-
STEP UP/ DOWN WHEN RATING CHANGES
No
STEP UP FIXED AT ISSUE
No
STEP DOWN FIXED AT ISSUE
No
BOND CALLABLE BY THE ISSUER
No
BOND IS SUBORDINATED
Yes

Tradability Information

Please log in to see the tradability information for this stock.

Not registered yet? Create your free account here.

Company profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.